Pfizer: Fourth Quarter Earnings Overview

Pfizer Reports Fourth Quarter Financial Results

Pfizer Inc., headquartered in New York, announced a net loss of $1.65 billion for the fourth quarter.

The company reported a loss of 29 cents per share. However, after adjusting for special items, earnings amounted to 66 cents per share.

These adjusted earnings surpassed analysts’ expectations, as a consensus of six analysts polled by Zacks Investment Research had anticipated earnings of 57 cents per share.

Pfizer’s revenue for the quarter reached $17.56 billion, outperforming projections. Four analysts surveyed by Zacks had estimated revenue at $16.84 billion.

Looking ahead, Pfizer forecasts its full-year earnings to fall between $2.80 and $3 per share, with projected revenue ranging from $59.5 billion to $62.5 billion.